Antibody Therapeutics
Country
United States
Northern America
Subject Area and Category
Immunology and Microbiology
└
Immunology
Q2
└
Immunology and Allergy
Q2
Publisher
SJR 2025
1.003
Q2
SJR Score
H-Index
30
Citations / Doc (2yr)
4.17
Total Docs. (latest)
26
Total Citations (3yr)
405
Publication type
Journals
ISSN
25164236
Coverage
2018-2026
Journal Rank
#4,893
Subject Categories
Immunology
Q2
Immunology and Allergy
Q2
Subject Areas
Aims & Scope
A peer-reviewed, online, open access journal, Antibody Therapeutics provides a forum for the publication of the latest advances and challenges in the discovery, research, development, manufacturing, and methodology of therapeutic antibodies for the global scientific community.
Topics include target and antibody discovery, mechanistic research, new technologies and methods, manufacturing, clinical trials, regulation, policies, and more.
Antibody Therapeutics article types include original research, reviews, cutting-edge technologies, new methods, news, interviews, and meeting highlights.
Abstracting & Indexing
Scopus
Google Scholar
Directory of Open Access Journals (DOAJ)
Embase
Detailed Metrics
| Total Docs. (latest) | 26 |
| Total Docs. (3 years) | 88 |
| Total Refs. | 2,191 |
| Total Citations (3 years) | 405 |
| Citable Docs. (3 years) | 88 |
| Citations / Doc. (2 years) | 4.17 |
| Ref. / Doc. | 84.27 |
| % Female | 42.5% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Antibody Therapeutics?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Antibody Therapeutics has an SJR of 1.003 and is ranked Q2.
What is the SJR and quartile of Antibody Therapeutics?
Antibody Therapeutics has an SJR (SCImago Journal Rank) of 1.003 and its best quartile is Q2.
What is the H-index of Antibody Therapeutics?
The H-index of Antibody Therapeutics is 30, meaning 30 of its articles have each been cited at least 30 times.
Is Antibody Therapeutics indexed in Scopus?
Yes. Antibody Therapeutics is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.